To examine the anti-NSCLC activity of DPBA in vivo, we established the tumour xenografts models of A549, H1650, and H1975 cells, and a xenograft derived from a patient with primary EGFR-positive lung cancer (Supplementary Fig. 4a). This evidence concerns the gene EGFR and lung cancer.